Highlights Wesana Health Holdings Inc.

Equities

WESA.X

CA95081C1059

Market Closed - Canadian Securities Exchange Other stock markets 08:07:40 27/06/2024 pm IST			5-day change	1st Jan Change
0.015 ^CAD	0.00%		-25.00%	+200.00%

30/05	Wesana Health Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03/05	Wesana Health Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Wesana Health Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	30/05	CI
Wesana Health Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03/05	CI
Wesana Health Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	29/11	CI
Wesana Health Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	29/23/29	CI
Wesana Health Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	30/23/30	CI
Wesana Health Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	03/23/03	CI
Wesana Health Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	29/22/29	CI
Wesana Sells Clinic Management Services Organization; Chief Marketing Officer Departs	02/22/02	MT
APS Innovations LLC acquired Advanced Psychiatric Management LLC from Wesana Health Holdings Inc. for USD 2.1 million.	01/22/01	CI
Wesana Health Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	30/22/30	CI
Wesana Health Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	30/22/30	CI
Wesana Health Holdings Outlines Accelerated Drug Development Pathway	10/22/10	CI
Wesana Health Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	02/22/02	CI
Wesana Explores Broadening SANA-013 Lead Indication to Treat Major Depressive Disorder	19/22/19	CI
Wesana Health Up 25% As Announces Positive Feedback From Pre-IND Meeting With FDA on SANA-013; Third Clinic to Open Spring 2022	14/22/14	MT
Wesana Health Brief: Up Near 25% As Announces Positive Feedback From Pre-IND Meeting With FDA on SANA-013; Also Provided Updates on Build-out of Third Clinic	14/22/14	MT
Wesana Health Holdings Announces Feedback from Pre-IND Meeting with Food and Drug Administration on SANA-013	14/22/14	CI
Wesana Provides Updates on Build-Out of Third Clinic	12/22/12	CI
Wesana Health Announces Positive Findings from Animal Study on Novel Depression Treatment Protocol Combining Psilocybin and Cannabidiol	18/22/18	CI
Wesana Health Holdings Inc. Grants US FDA Pre-IND Meeting for SANA-013	11/22/11	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Wesana Health Holdings Inc.

Equities

WESA.X

CA95081C1059

Highlights

Filters